GPG ME_Risk Minimisation II_DRAFT_PC

First Page		Document Content
Date: 2015-04-14 11:49:16 Pharmaceutical sciences Patient safety Pharmacy Medical terms Clinical research European Medicines Agency Pharmacovigilance Medical error Adverse effect Medicine Health Pharmacology		GPG ME_Risk Minimisation II_DRAFT_PC Add to Reading List Source URL: static.correofarmaceutico.com Download Document from Source Website File Size: 330,99 KB Share Document on Facebook

	The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections EMEA/CVMPFINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS DocID: 1vrLd - View Document
	7 May 2018 EMAHuman Medicines Research and Development Support Division European Medicines Agency Guidance for applicants seeking access to PRIME scheme DocID: 1vlIp - View Document
	The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 23 January 2003 CPMP/SWP DocID: 1ucvu - View Document
	2 March 2016 EMAExternal guidance on the implementation of the European Medicines Agency policy on the publication of clinical data for medicinal products for human use DocID: 1sVev - View Document
	European Medicines Agency: Celebrating 20 years DocID: 1sUY9 - View Document